COVID-19 Infection and Risk for Neuropsychiatric Symptoms
- PMID: 36075670
- PMCID: PMC9441783
- DOI: 10.1016/j.biopsych.2022.06.032
COVID-19 Infection and Risk for Neuropsychiatric Symptoms
Comment on
-
Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability.Biol Psychiatry. 2022 Oct 1;92(7):543-551. doi: 10.1016/j.biopsych.2022.03.009. Epub 2022 Mar 19. Biol Psychiatry. 2022. PMID: 35606186 Free PMC article.
References
-
- Reis G., dos Santos Moreira-Silva E.A., Silva D.C.M., Thabane L., Milagres A.C., Ferreira T.S., et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: The TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022;10:e42–e51. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
